COMPANY

Suzhou Lixin Pharmaceutical Co., Ltd.

Name: Suzhou Lixin Pharmaceutical Co., Ltd. peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Suzhou Lixin Pharmaceutical Co., Ltd.: bulk ingredient labeler for Semaglutide, Tirzepatide, as stated by public registers.

BULK INGREDIENT LABELER

Lists the bulk active ingredient with FDA (NDC directory).

Semaglutide	semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA
Tirzepatide	tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.